Online citations, reference lists, and bibliographies.
← Back to Search

Considerations And Challenges For Pregnancy In Polycystic Ovary Syndrome

C. Han, E. Werner
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Although the relationship of polycystic ovary syndrome (PCOS) with subfertility is well established, postconception implications of PCOS on pregnancy remain debated. Increased risk for miscarriage, gestational diabetes, hypertensive diseases of pregnancy, intrauterine growth abnormalities, perinatal mortality, and operative delivery are described in women with PCOS. Unfortunately, our understanding of definitive causal relationship to the observed associations is limited by the heterogeneity of the syndrome as well as by a paucity of large randomized controlled trials studying pregnancy in PCOS.
This paper references
10.1038/KI.1980.134
Management of preeclampsia and eclampsia.
J. Pritchard (1980)
10.1136/bmj.297.6655.1027
Recurrent early miscarriage and polycystic ovaries.
M. Sagle (1988)
10.1210/JCEM-67-2-341
Role of gestational hormones in the induction of insulin resistance.
E. Ryan (1988)
10.1111/j.1471-0528.1992.tb14470.x
Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin
D. Hamilton‐Fairley (1992)
10.1093/OXFORDJOURNALS.HUMREP.A138703
An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases.
K. Clifford (1994)
10.1016/S0002-9343(99)80057-6
Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.
A. Dunaif (1995)
10.1136/bmj.312.7045.1508
Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial
K. Clifford (1996)
10.1016/S0015-0282(98)00007-7
Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.
M. Okon (1998)
10.1210/JCEM.83.4.4707
High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.
J. Holte (1998)
10.1016/S0026-0495(99)90250-0
Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.
C. Glueck (1999)
10.1016/S0015-0282(00)00630-0
Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage.
C. Glueck (2000)
10.1093/HUMREP/15.3.612
Polycystic ovaries and recurrent miscarriage--a reappraisal.
R. Rai (2000)
10.1097/00003081-200003000-00001
Diabetes in pregnancy
P. Catalano (2000)
10.1093/HUMREP/16.12.2606
Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.
J. Wang (2001)
10.1016/S0015-0282(02)03247-8
Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss.
L. Craig (2002)
10.1016/S0015-0282(01)03202-2
Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.
C. Glueck (2002)
10.1093/HUMUPD/8.5.463
Recurrent miscarriage: aetiology, management and prognosis.
T. Li (2002)
10.1210/JCEM.87.2.8207
Effects of metformin on early pregnancy loss in the polycystic ovary syndrome.
D. Jakubowicz (2002)
10.1007/s00404-003-0537-2
The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome
M. Al-Azemi (2003)
10.1097/01.OGX.0000109523.25076.E2
Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
R. Legro (2004)
10.1210/JC.2003-030975
Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy.
D. Jakubowicz (2004)
10.1210/JC.2004-0689
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.
S. Palomba (2004)
10.1136/bmj.328.7433.192
Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial
N. Bayram (2004)
10.1016/S0015-0282(03)01188-9
Men at risk: occupation and male infertility.
P. Claman (2004)
10.1016/J.FERTNSTERT.2003.10.004
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
B. Fauser (2004)
10.1097/01.AOG.0000172422.81496.57
Prepregnancy Obesity and Fetal Death: A Study Within the Danish National Birth Cohort
E. Nohr (2005)
10.1210/JC.2005-0110
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.
S. Palomba (2005)
10.1093/HUMREP/DEH891
Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome.
M. van Wely (2005)
10.1136/bmj.38380.674340.E0
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
K. Duckitt (2005)
10.1056/NEJMOA042973
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
C. Crowther (2005)
10.1093/HUMUPD/DML017
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
S. K. Blank (2006)
10.1093/HUMUPD/DML036
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.
C. Boomsma (2006)
10.1055/s-2007-992927
Pregnancy complications in women with polycystic ovary syndrome.
C. Boomsma (2008)
10.1016/S1472-6483(10)60304-5
A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage.
K. Cocksedge (2008)
10.1056/NEJMoa0707193
Metformin versus insulin for the treatment of gestational diabetes.
J. Rowan (2008)
10.1111/j.1467-789X.2008.00541.x
Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta‐analysis
M. R. Torloni (2009)
10.1016/j.fertnstert.2008.08.087
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
S. Palomba (2009)
10.1210/jc.2010-0853
Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study.
E. Vanky (2010)
10.1136/bmj.d6309
Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study
N. Roos (2011)
10.1002/14651858.CD007506.pub3
Lifestyle changes in women with polycystic ovary syndrome.
L. Moran (2011)
10.1002/14651858.CD003053.pub5
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
T. Tang (2012)
10.1111/j.1600-0412.2012.01385.x
Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview
G. Ghazeeri (2012)
10.1097/MED.0b013e328359ff92
Reproductive impact of polycystic ovary syndrome
R. Usadi (2012)
Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice
R. K. Creasy (2013)
10.1185/03007995.2012.755121
Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome
C. Glueck (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar